Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy

Europace

Volumn 11, Issue 12, 2009, Pages 1647-1653

  Singh, Jagmeet P ^a   Rosenthal, Lawrence S ^b   Hranitzky, Patrick M ^c   Berg, Kellie Chase ^d   Mullin, Christopher M ^e   Thackeray, Lisa ^e   Kaplan, Andrew ^f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Boston Scientific CRM   (United States)

^e Integra Group   (United States)

^f Cardiovascular Associates of Mesa   (United States)

Author keywords

Autonomic nervous system; Biventricular pacing; Heart failure; Heart rate; Heart rate variability; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HEART RATE; HEART RATE VARIABILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; THEORETICAL MODEL; THERAPY EFFECT; TREATMENT OUTCOME; VALIDATION PROCESS;

AGED; CARDIAC PACING, ARTIFICIAL; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 71449086867     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup250     Document Type: Article

References (21)

1. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033 (Pubitemid 34628286)
2. Auricchio A, Ding J, Spinelli JC, Kramer AP, Salo RW, Hoersch W et al. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. J Am Coll Cardiol 2002; 39:1163-1169 (Pubitemid 34267420)
3. Auricchio A, Kloss M, Trautmann SI, Rodner S, Klein H. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Am J Cardiol 2002;89:198-203. (Pubitemid 34132910)
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549 (Pubitemid 40517094)
6. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346: 1845-1853
7. Yu CM, Wing-Hong FJ, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy-current and future perspectives. J Cardiovasc Electrophysiol 2005;16:1117-1124
8. Kadhiresan VA, Pastore J, Auricchio A, Sack S, Doelger A, Girouard S et al. A novel method-the activity log index-for monitoring physical activity of patients with heart failure. Am J Cardiol 2002;89:1435-1437
9. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc; 2000.
10. Gilliam FR III, Singh JP, Mullin CM, McGuire M, Chase KJ. Prognostic value of heart rate variability footprint and standard deviation of average 5-minute intrinsic R-R intervals for mortality in cardiac resynchronization therapy patients. J Electrocardiol 2007;40:336-342
11. Gilliam FR III, Kaplan AJ, Black J, Chase KJ, Mullin CM. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry. Pacing Clin Electrophysiol 2007;30:56-64.
12. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation 2003;108:266-269
13. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004;110:2389-2394
14. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-1433
15. Fung JW, Chan JY, Kum LC, Chan HC, Yip GW, Zhang Q et al. Suboptimal medical therapy in patients with systolic heart failure is associated with less improvement by cardiac resynchronization therapy. Int J Cardiol 2007;115: 214-219
16. Vanderheyden M, De Backer T, Rivero-Ayerza M, Geelen P, Bartunek J, Verstreken S et al. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy. Heart Rhythm 2005;2:1066-1072
17. Hardt SE, Yazdi SH, Bauer A, Filusch A, Korosoglou G, Hansen A et al. Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy. Int J Cardiol 2007;115:318-325
18. Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: a case- control study. J Interv Card Electrophysiol 2007;19:201-207
19. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007;9:258-265
20. Mathew J, Hunsberger S, Fleg J, Mc Sherry F, WillifordW, Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 2000;118:914-922
21. Germany R, Murray C. Use of device diagnostics in the outpatient management of heart failure. Am J Cardiol 2007;99:11-6G.